Evidence map›Paper›PMID 34208764›Full record

ArticleBiomedicines2021

Prevalence and Risk Factors of Infection with High Risk Human Papilloma Viruses among HIV-Positive Women with Clinical Manifestations of Tuberculosis in a Middle-Income Country.

Maria Isaguliants, Marina Nosik, Anastasia Karlsen, Natalia Petrakova, Marina Enaeva, Natalia Lebedeva, Daria Podchufarova, Vita Laga, Konstantin Gromov, Anatoly Nazarov and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Maria IsaguliantsDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID 0000-0001-9382-2254
Marina NosikI.I. Mechnikov Institute of Vaccine and Sera, 105064 Moscow, Russia.ORCID 0000-0002-0857-9358
Anastasia KarlsenN.F. Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.ORCID 0000-0002-6013-7768
Natalia PetrakovaN.F. Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
Marina EnaevaMoscow Clinical Scientific Center Named after A.S. Loginov, 111123 Moscow, Russia.
Natalia LebedevaMoscow Regional Center for Prevention and Control of AIDS and Infectious Diseases, 129110 Moscow, Russia.
Daria PodchufarovaMoscow Regional Center for Prevention and Control of AIDS and Infectious Diseases, 129110 Moscow, Russia.
Vita LagaN.F. Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
Konstantin GromovN.F. Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.ORCID 0000-0002-9316-1975
Anatoly NazarovWest Medica, 129075 Moscow, Russia.
Sona ChowdhuryDepartment of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Mikhail SinitsynMoscow Scientific and Clinical Center for TB Control, 107076 Moscow, Russia.
Alexander SobkinG.A. Zaharyan Moscow Tuberculosis Clinic, Department for Treatment of TB Patients with HIV Infection, 125466 Moscow, Russia.
Natalya ChistyakovaG.A. Zaharyan Moscow Tuberculosis Clinic, Department for Treatment of TB Patients with HIV Infection, 125466 Moscow, Russia.
Svetlana AleshinaMoscow Scientific and Clinical Center for TB Control, 107076 Moscow, Russia.
Alexei GrabarnikMoscow Scientific and Clinical Center for TB Control, 107076 Moscow, Russia.
Joel M PalefskyDepartment of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Moscow Clinical Scientific Center · RURegional Center for Prevention and Control of AIDS and Infectious Diseases · RUUniversity of California, San Francisco · USKarolinska Institutet · SEResearch Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences · RURussian Medical Academy of Continuous Professional Education · RU

Funding

NIH HHS R01 CA217715/CA/NCIRussian Fund for Basic Research RFBR 17-54-30002
6 · The paper itself

Abstract

Women living with HIV-1 are at high risk of infection with human papillomavirus of high carcinogenic risk (HR HPVs).

Indexed as

AIDSART and TB treatmentclinical TB manifestationsM. tuberculosisprevalence of high risk HPVssequence of HPV 16 E6 and E7sociodemographic characteristicstherapeutic HPV vaccinewomen living with HIV-1

Identifiers

PMID34208764
PMCPMC8234035
OpenAlexW3173808507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.